Molecular Imaging: Page 72

Voxel-based technique improves tau PET for Alzheimer's disease

By Will Morton

A new technique that tracks individual voxels on tau PET scans in patients with Alzheimer's disease appears effective for detecting early signs of the disease, according to a study published March 17 in the Journal of Nuclear Medicine.

March 20, 2022

FluoGuide gives details on brain cancer research in Denmark

By AuntMinnie.com staff writers

FluoGuide said a research grant connected to its work with Rigshospitalet in Copenhagen, Denmark, will help it set up a phase II trial for the company's FG001 radiopharmaceutical candidate in patients with less aggressive brain cancers.

March 17, 2022

Tc-99m SPECT/CT imaging detects COVID-19

By Will Morton

Iranian nuclear medicine physicians diagnosed COVID-19 in an asymptomatic patient undergoing technetium-99m (Tc-99m) SPECT/CT imaging for prostate cancer, according to a March 15 report in the Egyptian Journal of Radiology and Nuclear Medicine.

March 17, 2022

Dutch isotope reactor restarts

By AuntMinnie.com staff writers

The High Flux Reactor (HFR) in Petten, the Netherlands, has restarted after a forced shutdown due to a water leak in January, with isotopes deliveries to hospitals expected within two weeks.

March 16, 2022

AC Immune show first images from alpha-synuclein PET

By AuntMinnie.com staff writers

Swiss biopharmaceutical company AC Immune has revealed the first noninvasive live images of alpha-synuclein in humans' brains using its new PET tracer for neurogenerative diseases.

March 15, 2022

IBA and Tractebel partner on construction projects

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has inked a partnership agreement with engineering company Tractebel to support IBA's customers with their proton therapy design and construction projects.

March 14, 2022

Immuno-PET reveals persistent HIV infection

By Will Morton

A new immuno-PET imaging method may offer a novel approach to detecting low levels of HIV in patients undergoing antiretroviral therapy (ART), according to a study published March 9 in Nature Communications.

March 14, 2022

SNMMI names radiopharma therapy centers of excellence

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named its first two designated radiopharmaceutical therapy centers of excellence: Stanford Health Care in Stanford, CA, and the Dana-Farber Brigham Cancer Center in Boston.

March 10, 2022

Cerveau to supply Roche with new PET tracer

By AuntMinnie.com staff writers

Cerveau Technologies has signed an agreement to provide Roche with the PET radiotracer F-18 MK-6240 for assessing the status and progression of tau neurofibrillary tangles in the brain.

March 9, 2022

NorthStar, Convergent ink Ac-225 supply deal

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and Convergent Therapeutics have entered into a supply agreement for the actinium-225 (Ac-225) medical radioisotope.

March 8, 2022

PET/CT predicts treatment outcomes in myeloma patients

By Will Morton

PET/CT can help predict which patients have better chances of survival after starting treatment for multiple myeloma, according to a study published March 3 in Blood Advances.

March 8, 2022

CT radiomics predicts rectal cancer treatment response

By Erik L. Ridley

Radiomics analysis of pretreatment CT exams can help to predict response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer, according to research presented at last week's ECR 2022 Overture.

March 7, 2022

Previous Page

Page 72 of 611

Next Page